Etiopathogenetic, Morphological, Diagnostic and Therapeutic Aspects of Acute Glomerulonephritis: Current Status

The review provides up-to-date information on the etiological factors and pathogenic mechanisms of development, morphological changes, clinical and laboratory manifestations of acute glomerulonephritis, as well as therapeutic possibilities for its treatment. The review provides up-to-date information on the etiological factors and pathogenetic mechanisms of development, morphological changes, clinical and laboratory manifestations of acute glomerulonephritis, as well as therapeutic possibilities for its treatment. The epidemiological issues of acute post-streptococcal glomerulonephritis are presented, indicating the characteristics of the effects of nephritogenic strains of Streptococcal infection. The immunopathological reactions of the body in acute glomerulonephritis to the causative agent of the disease and its antigens with the development of an imbalance of subpopulations of T-lymphocytes, the nephritogenic potential of streptococcal proteins, a marker of active proliferation of mesangiocytes, C3 and C4 fractions of complement, and also the renin-angiotensin-aldosterone system are shown. The article emphasizes that the informational content of serological tests in acute glomerulonephritis increases while assessing the C3 and C4 fractions of serum complement. The pathological effects of angiotensin II and aldosterone on the renal tissue with the chronization of acute glomerulonephritis, the development of nephrotic proteinuria and a rapid decrease in renal function are presented. The data of a direct correlation between the severity of histological changes and the clinical manifestations of acute glomerulonephritis, possibly the prognosis, are shown. Presented are modern data on the assessment of the main clinical manifestations of acute glomerulonephritis (urinary syndrome, edema syndrome and arterial hypertension). When discussing the treatment of acute glomerulonephritis, the controversial issues of the use of antibiotic therapy, preventive tonsillectomy are noted. The literature data on the treatment options for edematous syndrome and arterial hypertension using thiazide and loop diuretics, calcium antagonists, beta-blockers, angiotensin converting enzyme inhibitors, angiotensin II receptor blockers are presented. The issues of immunosuppressive therapy using glucorticoids, as well as prognostic criteria for acute glomerulonephritis are discussed.

1. Mukhin N.A., Glybochko P.V., Svistunov A.A. et al. Acute glomerulonephritis in the XXI century. Therapeutic Archive. 2015;87(6):4-9. doi: 10.17116/terarkh20158764-9 [in Russian].

2. Shulutko B.I., Makarenko S.V. Acute glomerulonephritis, and not only in the xxi century. Nephrology (Saint-Petersburg). 2015;19(6):14-9. [in Russian].

3. Kupin W.L. Viral-Associated GN: Hepatitis B and other viral infections. Clin J Am Soc Nephrol. 2017;12(9):1529-33. doi: 10.2215/CJN.09180816.

4. Prasad N., Novak J.E., Patel M.R. Kidney diseases associated with parvovirus B19, hanta, Ebola, and dengue virus infection: a brief review. Adv Chronic Kidney Dis. 2019;26(3):207-19. doi: 10.1053/j.ackd.2019.01.006.

5. Ryabov S.I., Rakityanskaya I.A., Abo-Asba N. Etiology of acute glomerulonephritis. Nephrology (Saint-Petersburg). 1999;3(4):7-16. doi: 10.24884/1561-6274-1999-3-4-7-16 [in Russian].

6. Nephrology. Textbook for postgraduate education, ed. E.M. Shilova. M.: GEOTAR-Media. 2007; 688 р. [in Russian].

7. Khasabov N.N., Malkoch A.V. Modern ideas about glomerulonephritis. In the book: Nephrology of childhood (under the editorship of V.A. Tabolin and others). M.: Publishing House Medpraktika-M. 2005; 306-90. [in Russian].

8. Papayan A.V., Savenkova N.D. Clinical Nephrology. St. Petersburg: Sotis. 1997; 712 р. [in Russian].

9. Floege J., Barbour S.J., Cattran D.C. et al. Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Kidney international. 2019;95(2):268-80. doi: 10.1016/j.kint.2018.10.018.

10. Volovat C., Caruntu I., Costin C. et al. Changes in the histological spectrum of glomerular diseases in the past 16 years in the NorthEastern region of Romania. BMC nephrology. 2013; 14(1):148. doi: 10.1186/1471-2369-14-148.

11. Wetmore J.B., Guo H., Liu J. et al. The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis. Kidney international. 2016; 90(4):853-60. doi: 10.1016/j.kint.2016.04.026.

12. Ralph A.P., Carapetis J.R. Group a streptococcal diseases and their global burden. Curr Top Microbiol Immunol. 2013; 368: 1-27, doi: 10.1007/82_2012_280.

13. Kagan M.Yu. Acute Post-Streptococcal Glomerulonephritis in Children. Voprosy sovremennoi pediatrii — Current Pediatrics. 2016;15(1):25-32. doi: 10.15690/vsp.v15i1.1497 [in Russian].

14. Bhalla K., Gupta A., Nanda S. et al. Epidemiology and clinical outcomes of acute glomerulonephritis in a teaching hospital in North India. J Family Med Prim Care. 2019; 8(3): 934-37. doi: 10.4103/jfmpc.jfmpc_57_19

15. Sharmin M., Chowdhury A.M., Ali M.A. et al. Clinical Profile and Immediate Outcome of Children Admitted With Acute Glomerulonephritis in Pediatrics Department of A Tertiary Level Hospital. Mymensingh Med J. 2020; 29(1): 5-15.

16. Bullen A., Shah M.M. De novo postinfectious glomerulonephritis secondary to nephritogenic streptococci as the cause of transplant acute kidney injury: A case report and review of the literature? Case Rep Transplant. 2018;2018:2695178 doi: 10.1155/2018/2695178.

17. Cattran D.C., Feehally J., Cook H.T. et al. Kidney disease: improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis.Kidney International Supplements. 2012;2(2):139-274. doi: 10.1038/kisup.2012.9

18. Shilov E.M., Kozlovskaya N.L., Korotchaeva J.V. Clinical guidelines for diagnosis and treatment of rapidly progressive glomerulonephritis (extracapillary glomerulonephritis with crescent formation). Nephrology (Saint-Petersburg). 2015; 19(6): 73-82. [in Russian].

19. Vitaliti G., Falsaperla R., Giunta L. et al. Acute glomerulonephritis in a child with Chlamydia pneumoniae infection: a case report. Case Rep Med. 2013; 2013:570921. doi: 10.1155/2013/570921.

20. Kanodia K.V., Vanikar A.V., Kute V.B., et al. Plasmodium vivax malaria associated with acute post infectious glomerulonephritis. Renal failure. 2013; 35(7):1024-26. doi: 10.3109/0886022X.2013.810119.

21. Stetson C.A., Rammelkamp C.H., Krause R.M. et al. Epidemic acute nephritis: studies on etiology, natural history and prevention. Medicine (Baltimore). 1955; 34(4): 431-50.

22. Anthony B.F., Kaplan E.L., Wannamaker L.W. et al. Attack rates of acute nephritis after type 49 streptococcal infection of the skin and of the respiratory tract. J Clin Invest. 1969; 48(9): 1697-1704. doi: 10.1172/JCI106135.

23. Baiter S., Baiter S., Benin A. et al. Epidemic nephritis in Nova Serrana, Brazil.The Lancet. 2000; 35(9217): 1776-80. doi: 10.1016/S0140-6736(00)02265-0.

24. Edwards P.R., Broh-Kahn R. A Note on the Hydrolysis of Sodium Hippurate by the Hemolytic Streptococci.Journal of bacteriology. 1934;27(5):535-38. PMID: 16559718.

25. Rodriguez-Iturbe B., Batsford S. Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int. 2007;71(11):1094-1104. doi: 10.1038/sj.ki.5002169.

26. Jankauskiene A., Pundziene B., Vitkevic R. Postinfectious glomerulonephritis in children in Lithuania during 1995-2004: prevalence and clinical features. Medicina (Kaunas). 2007; 43:16-22. PMID: 17551271.

27. Nasr S.H., Markowitz G.S., Stokes M.B. et al. Acute postinfectious glomerulonephritis in the modern era: experience with 86 adults and review of the literature. Medicine (Baltimore). 2008; 87(1):21-32. doi: 10.1097/md.0b013e318161b0fc.

28. Kersnik Levart T. Post-vaccine glomerulonephritis in an infant with hereditary C2 complement deficiency: case study. Croatian medical journal. 2013;54(6):569-73. doi: 10.3325/cmj.2013.54.569.

29. Martire B., Azzari C., Badolato R. et al. Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET). Vaccine. 2018; 36(24): 3541-3554. doi: 10.1016/j.vaccine.2018.01.061.

30. Fiorentino M., Bolignano D., Tesar V. et al. ERA-EDTA Immunonephrology Working Group. Renal biopsy in 2015-from epidemiology to evidence-based indications. American Journal of Nephrology. 2016; 43(1):1-19. doi: 10.1159/000444026.

31. Gozdzik M., Ptuciennik A., Zawiasa-Bryszewska A. et al. Acute Kidney Injury Following Exposure to Calcineurin Inhibitors in a Patient with Idiopathic Membranous Nephropathy. Drug safety-case reports. 2019;6(1):9. doi: 10.1007/s40800-019-0103-x.

32. Mamedov M.K. The doctrine of the epidemic process as an ideological basis for the development of the epidemiology of infectious and parasitic diseases. Biomedicine (Baku). 2012;2:25-36. [in Russian].

33. Stevens D.L., Bryant A.E. Impetigo, erysipelas and cellulitis. Streptococcus pyogenes: Basic Biology to Clinical Manifestations. University of Oklahoma Health Sciences Center, 2016. [Electronic resource]. URL: https://www.ncbi.nlm.nih.gov/books/NBK333424 (date of the application: 05.02.2020).

34. Bessa G. Bacterial Infections.Dermatology in Public Health Environments. Springer, Cham. 2018; 157-72. doi: 10.1007/978-3-319-33919-1_9.

35. Pinto S.W., Sesso R., Vasconcelos E. et al. Follow-up of patients with epidemic poststreptococcal glomerulonephritis.Am.J. Kidney Dis. 2001;38(2):249-55. doi: 10.1053/ajkd.2001.26083.

36. Sesso R., Pinto S.W. Five-year follow-up of patients with epidemic glomerulonephritis due to Streptococcus zooepidemicus.Nephrol. Dial Transplant. 2005;20(9):1808-12. doi: 10.1093/ndt/gfh904.

37. Zheng M.H., Jiao Z.Q., Zhang L.J. et al. Genetic analysis of group A streptococcus isolates recovered during acute glomerulonephritis outbreaks in Guizhou Province of China. J Clin Microbiol. 2009;47(3):715-20. doi: 10.1128/jcm.00747-08.

38. Abraham T., Sistla S. Trends in antimicrobial resistance patterns of Group A streptococci, molecular basis and implications. Indian journal of medical microbiology. 2018;36(2):186. doi: 10.4103/ijmm.i|MM_18_107.

39. Muhtarova A., Mihova K., Markovska R. et al. Molecular emm typing of Bulgarian macrolide-resistant Streptococcus pyogenes isolates.Acta Microbiologica et Immunologica Hungarica. 2019;1 -4. doi: 10.1556/030.66.2019.033.

40. Ryabov S.I., Rakityanskaya I.A. Nephrology: a guide for doctors: in 2 volumes. SPb.: SpetsLit. 2013; 767 p. [in Russian].

41. Malkoch A.V., Nikolaev A.Yu., Filatova N.N. Acute poststreptococcic (post-infectious) glomerulonephritis. Lechaschii Vrach. 2017; 1: 44-8. [in Russian]. ISSN: 1560-5175.

42. Oda T., Yoshizawa N., Yamakami K. et al. Significance of glomerular cell apoptosis in the resolution of acute poststreptococcal glomerulonephritis. Nephrol Dial Transplant. 2007; 22(3): 740-48. doi: 10.1093/ndt/gfl712

43. Yoshizawa N., Oshima S., Sagel I. et al. Role of a streptococcal antigen in the pathogenesis of acute poststreptococcal glomerulonephritis. Characterization of the antigen and a proposed mechanism for the disease. J.Immunol. 1992;148(10):3110-6.

44. Bobkova I.N., Shestakova M.V., Schukina A.A. Diabetic nephropathy — focus on podocytes damage. Nephrology. 2015;19(2):33-44. [in Russian].

45. Gadau J., Peters H., Kastner C. et al. Mechanisms of tubular volume retention in immune-mediated glomerulonephritis. Kidney Int. 2009;75(7):699-710. doi: 10.1038/ki.2008.649.

46. Torban E., Braun F., Wanner N. et al. From podocyte biology to novel cures for glomerular disease. Kidney international. 2019;96(4):850-61. doi: 10.1016/j.kint.2019.05.015.

47. Viera N., Pedreanez A., Rincon J. еt al. Streptococcal zymogen type B induces angiotensin II in mesangial cells and leukocytes. Pediatr. Nephrol. 2009;24(5):1005-11. doi: 10.1007/s00467-008-1105-6.

48. Shilov E.M., Bobkova I.N., Kamysheva E.S. et al. Clinical recommendations «Diagnosis and treatment of acute poststreptococcal glomerulonephritis» Moscow. 2014; 16 р. [in Russian].

49. Haider D.G., Friedl A., Peric S. et al. Kidney biopsy in patients with glomerulonephritis: is the earlier the better? BMC nephrology. 2012;13(1):34. doi: 10.1186/1471-2369-13-34

50. Gashti C.N., Baxi P.V., Whittier W.L. et al. The Renal Biopsy in Chronic Kidney Disease.Chronic Renal Disease. Academic Press. 2020;1207-22. doi: 10.1016/B978-0-12-815876-0.00073-5.

51. Pezeshki Rad M., Taghavi M., Hashemi J. et al. Renal biopsy in glomerulonephritis. Rev Clin Med. 2014; 1(2):71-4. doi: 10.17463/RCM.2014.02.007,

52. Sievers L.K., Eckardt K.U. Molecular mechanisms of kidney injury and repair in arterial hypertension.International journal of molecular sciences. 2019;20(9):2138. doi: 10.3390/ijms20092138.

53. Eng D.G., Kaverina N.V., Schneider R.R. et al. Detection of renin lineage cell transdifferentiation to podocytes in the kidney glomerulus with dual lineage tracing. Kidney international. 2018;93(5):1240-6. doi: 10.1016/j.kint.2018.01.014.

54. Tirikova O.V., Filatova I.A. Glomerulonephritis: a training manual. Ed.N. M. Kozlova; FSBEI IN IGMU of the Ministry of Health of Russia. Department of Faculty Therapy. Irkutsk: IGMU. 2017; 44 р. [in Russian].

55. Cunningham M.W. Pathogenesis of group A streptococcal infections. Clinical microbiology reviews. 2000;13(3):470-511. doi: 10.1128/CMR.13.3.470.

56. Sanjad S., Tolaymat A., Whitworth J. еt al. Acute glomerulonephritis in children: a review of 153 cases. South Med J. 1977;70(10):1202-6. doi: 10.1097/00007611-197710000-00015

57. Lange K., Azadegan A.A., Seligson G. et al. Asymp tomatic post streptococcal glomerulonephritis in relatives of patients with symptomatic glomerulonephritis. Diagnostic value of endostreptosin antibodies. Child Nephrol Urol. 1988;9(1-2):11-5.

58. Pan C.G., Avner E.D. Acute post streptococcal glomerulonephritis. In: Nelson's textbook of pediatrics. Ed. Kliegman R.M., Stanton B.M., St. Geme J., Schor N., Behrman R.E. Philadelphia: Elsevier Saunders. 2015;2498-501

59. Parks T., Smeesters P.R., Curtis N. еt al. ASO titer or not? When to use streptococcal serology: a guide for clinicians. Eur J Clin Microbiol Infect Dis. 2015;34(5):845-9. doi: 10.1007/s10096-014-2303-8

60. Blyth C.C., Robertson P.W., Rosenberg A.R. Post-streptococcal glomerulonephritis in Sydney: a 16-year retrospective review. J Paediatr Child Health. 2007;43(6):446-50 doi: 10.1111/j.1440-1754.2007.01109.x

61. Paula J.S., Cruz A.A. V,, Akaishi P.M., Burman T.Acute hypocomplementemic post-infectious glomerulonephritis as a complication of sinus-related orbital cellulitis: case report. Arq Bras Oftalmol. 2008;71(4):579-80. doi: 10.1590/S0004-27492008000400021

62. Eison T.M., Ault B.H., Jones D.P. et al. Poststreptococcal acute glomerulonephritis in children: clinical features and pathogenesis. Pediatr Nephrol. 2011;26:165-80. doi: /10.1007/s00467-010-1554-6.

63. Rene G. Van De Voorde III. Acute poststreptococcal glomerulonephritis: the most common acute glomerulonephritis. Pediatrics in review. 2015;36(1):3-12. doi: 10.1542/pir.36-1-3

64. Van Driel M.L., De Sutter A.I., Keber N. et al. Different antibiotic treatments for group A streptococcal pharyngitis. Cochrane Database Syst Rev. 2013;30(4):CD004406. doi: 10.1002/14651858.CD004406.